These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 24598959)

  • 1. Cyclosporine A-enhanced cardioplegia preserves mitochondrial basal respiration after ischemic arrest.
    Hoyer AA; Klaeske K; Garnham J; Kiefer P; Salameh A; Witte K; Borger M; Dieterlen MT
    Perfusion; 2024 Jan; 39(1):36-44. PubMed ID: 34192950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gas-loaded nanocarriers to improve cardioprotection by cardioplegic solution.
    Rubeo C; Giordano M; Tannous M; Duràn AM; Comità S; Landolfi V; Aragno M; Cavalli R; Penna C; Trotta F; Pagliaro P
    Vascul Pharmacol; 2024 Jun; 155():107346. PubMed ID: 38985624
    [No Abstract]   [Full Text] [Related]  

  • 3. Myocardial protection: comparing histological effects of single-dose cardioplegic solutions-study protocol for a secondary analysis of the CARDIOPLEGIA trial.
    Lira KB; Delvaux RS; Spadini FA; Hauschild LH; Ceron RO; Anschau F; Kopittke L; Rode J; Rey RAW; Wittke EI; Rombaldi AR; Cambruzzi E; Lopes ERC; Almeida AS
    J Thorac Dis; 2024 Feb; 16(2):1480-1487. PubMed ID: 38505015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperkalemic or Low Potassium Cardioplegia Protects against Reduction of Energy Metabolism by Oxidative Stress.
    Diao H; Gu H; Chen QM
    Antioxidants (Basel); 2023 Feb; 12(2):. PubMed ID: 36830011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Insights into the Cardioprotective Effects of the Peptides of the Counter-Regulatory Renin-Angiotensin System.
    Gamiño-Gutiérrez JA; Terán-Hernández IM; Castellar-Lopez J; Villamizar-Villamizar W; Osorio-Llanes E; Palacios-Cruz M; Rosales W; Chang AY; Díaz-Ariza LA; Ospino MC; Mendoza-Torres E
    Biomedicines; 2024 Jan; 12(2):. PubMed ID: 38397857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Strategies to Improve the Cardioprotective Effects of Cardioplegia.
    Osorio-Llanes E; Castellar-López J; Rosales-Rada W; Montoya Y; Bustamante J; Zalaquett R; Bravo-Sagua R; Riquelme JA; Sánchez G; Chiong M; Lavandero S; Mendoza-Torres E
    Curr Cardiol Rev; 2024 Jan; 20(1):. PubMed ID: 38275069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histidine-tryptophan-ketoglutarate solution versus multidose cardioplegia for myocardial protection in cardiac surgeries: a systematic review and meta-analysis.
    Albadrani M
    J Cardiothorac Surg; 2022 May; 17(1):133. PubMed ID: 35642063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developments in cardioprotection: "polarized" arrest as an alternative to "depolarized" arrest.
    Chambers DJ; Hearse DJ
    Ann Thorac Surg; 1999 Nov; 68(5):1960-6. PubMed ID: 10585111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of cardioplegic solution without potassium: experimental study in rat.
    Reichert K; Carmo HR; Lima F; Torina AG; Vilarinho KA; Oliveira PP; Silveira Filho LM; Severino ES; Petrucci O
    Rev Bras Cir Cardiovasc; 2013; 28(4):524-30. PubMed ID: 24598959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lidocaine and Pinacidil Added to Blood versus Crystalloid Cardioplegic Solutions: Study in Isolated Hearts.
    Carmo HPD; Reichert K; Carvalho DD; Silveira-Filho LDM; Vilarinho K; Oliveira P; Petrucci O
    Braz J Cardiovasc Surg; 2018; 33(3):211-216. PubMed ID: 30043912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioprotection by sevoflurane against reperfusion injury after cardioplegic arrest in the rat is independent of three types of cardioplegia.
    Ebel D; Preckel B; You A; Müllenheim J; Schlack W; Thämer V
    Br J Anaesth; 2002 Jun; 88(6):828-35. PubMed ID: 12173202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of HTK solution for myocardial preservation.
    Hachida M; Ookado A; Nonoyama M; Koyanagi H
    J Cardiovasc Surg (Torino); 1996 Jun; 37(3):269-74. PubMed ID: 8698763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical evaluation of coronary vascular function after cardioplegia with HTK and different antioxidant additives.
    Schröder C; Heintz A; Pexa A; Rauen U; Deussen A
    Eur J Cardiothorac Surg; 2007 May; 31(5):821-6. PubMed ID: 17321142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Cardioplegia on the contractile apparatus level": evaluation of a new concept for myocardial preservation in perfused pig hearts.
    Vahl CF; Bonz A; Hagl C; Timek T; Herold U; Fuchs H; Kochsiek N; Hagl S
    Thorac Cardiovasc Surg; 1995 Aug; 43(4):185-93. PubMed ID: 7502280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Custodiol versus blood cardioplegia in complex cardiac operations: an Australian experience.
    Viana FF; Shi WY; Hayward PA; Larobina ME; Liskaser F; Matalanis G
    Eur J Cardiothorac Surg; 2013 Mar; 43(3):526-31. PubMed ID: 22665382
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.